Jonathan L. Schechter

Jonathan L. Schechter is recorded as Board Member at PharmaCyte Biotech, Inc. (PMCB) and Board Member at TAO Synergies Inc. (TAOX) since October 11, 2022. The newest filing on record that lists Jonathan L. Schechter as Board Member at PharmaCyte Biotech, Inc. (PMCB) is dated March 9, 2026. PharmaCyte Biotech, Inc. reported in an 8-K filed April 2, 2026 that Jonathan L. Schechter was appointed Director, effective March 30, 2026. TAO Synergies Inc. reported in an 8-K filed August 29, 2025 that Jonathan L. Schechter resigned as member of the board of directors, effective August 28, 2025. TAO Synergies Inc. reported in an 8-K filed October 13, 2022 that Jonathan L. Schechter was appointed Director, effective October 11, 2022. Equibles holds 5 filed executive changes naming Jonathan L. Schechter; each is listed under recent activity with its source filing. PharmaCyte Biotech, Inc. is classified in the Biotechnology industry within the Healthcare sector. TAO Synergies Inc. is classified in the Capital Markets industry within the Financial Services sector. Other leadership on record at PharmaCyte Biotech, Inc. includes Joshua N. Silverman (CEO, Chairman and Board Member), Joshua Silverman (CEO), Gerald W. Crabtree (CTO) and 5 others.